Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Encision Inc (OP: ECIA )

0.4500 UNCHANGED
Streaming Delayed Price Updated: 3:54 PM EST, Dec 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.4500
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.4500
Today's Range 0.4500 - 0.4500
52wk Range 0.2470 - 0.7500
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Encision Reports Second Quarter Fiscal Year 2025 Results
Via ACCESSWIRE
ThredUp And 2 Other Penny Stocks Executives Are Buying
Via Benzinga

Performance

YTD
+5.88%
+5.88%
1 Month
+9.76%
+9.76%
3 Month
+15.38%
+15.38%
6 Month
+7.14%
+7.14%
1 Year
+5.88%
+5.88%

More News

Read More
Encision Signs Master Services Agreement with Vicarious Surgical Inc.
Via ACCESSWIRE
Encision Reports First Quarter Fiscal Year 2025 Results
Via ACCESSWIRE
Encision Reports Fourth Quarter Fiscal Year 2024 Results
Via ACCESSWIRE
Encision Reports Third Quarter Fiscal Year 2024 Results
Via ACCESSWIRE
Encision Reports Second Quarter Fiscal Year 2024 Results
Via ACCESSWIRE
Encision Reports First Quarter Fiscal Year 2024 Results
Via ACCESSWIRE
Encision Reports Fourth Quarter Fiscal Year 2023 Results
Via ACCESSWIRE
Encision Signs Supplier Agreement with Human Xtensions
Via ACCESSWIRE
Encision Reports Third Quarter Fiscal Year 2023 Results
Via ACCESSWIRE
Encision Reports Second Quarter Fiscal Year 2023 Results
Via ACCESSWIRE
Encision Reports First Quarter Fiscal Year 2023 Results
Via ACCESSWIRE
Encision Reports Fourth Quarter Fiscal Year 2022 Results
From Encision, Inc.
Via AccessWire
Topics Economy
Exposures COVID-19 Supply Chain
Encision Reports Third Quarter Fiscal Year 2022 Results
From Encision, Inc.
Via AccessWire
4 Penny Stocks Insiders Are Buying: CymaBay Therapeutics, Avalo Therapeutics And More
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.